Edit Module

New Joint Venture Launches Canine Lymphoma Test



Published:

A new canine lymphoma diagnostic kit can differentiate patients with lymphadenopathy due to lymphoma from ones with lymphadenopathy due to other ailments, such as lymphoid hyperplasia.

The Tri-Screen Canine Lymphoma Assay Kit is the first product to be offered by Tri-Screen—a new joint venture between Ireland-based animal diagnostic technology firm Tridelta Development Ltd. and animal cancer test developer Petscreen Ltd. of the U.K.

Petscreen developed the Advanced Lymphoma Blood Test on which the kit is based. The test combines relative values of the acute phase proteins haptoglobin and C-reactive protein in a patient’s blood serum into an analytical algorithm to determine if a patient’s lymphadenopathy is due to lymphoma or another ailment.

Petscreen enlisted support from veterinarians in the U.S. and the U.K. to test the method on samples from 194 canine patients with lymphoma, diseases with similar presentation to lymphoma, and healthy dogs.

Petscreen said it partnered with Tridelta because of the company’s reputation and experience with the international pharmaceutical industry in the niche sector of manufacturing and marketing acute phase protein diagnostic kits.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Ross University Launches iPad Program for Vet Students

Incoming 2016 students at Ross University School of Veterinary Medicine will receive a free iPad custom-designed with learning apps to help enhance their learning experience.

Purina Reformulates Beneful Dog Food

Beef or chicken move to the top of the ingredients list, while a controversial additive is dropped.

Diamond Releases Vet-Exclusive Dog Food

Rx Renal Formula is one of five new recipes from Diamond Pet Foods.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module